Efficacy and safety of mavacoxib in the treatment of pain and inflammation associated with degenerative joint disease in dogs presented as veterinary patients

Journal of Veterinary Pharmacology and Therapeutics

Volumn 32, Issue SUPPL. 1, 2009, Pages 106-107

  Payne Johnson, M ^a   Boucher, J F ^b   Stegemann, M R ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARPROFEN; CYCLOOXYGENASE 2 INHIBITOR; MAVACOXIB; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL LAMENESS; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; BLOOD SAMPLING; CONFERENCE PAPER; CONTROLLED STUDY; DEGENERATIVE DISEASE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; EXPERIMENTAL DOG; JOINT RADIOGRAPHY; LOADING DRUG DOSE; MUSCULOSKELETAL PAIN; NONHUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; SCORING SYSTEM; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; WEIGHT BEARING;

CANIS FAMILIARIS;

EID: 68149136190     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (0)